Finance

Beta
Lists
NAV:CVE
Navco Pharmaceuticals Inc
CA$0.010
0.00%
(0.00) 1D
Jun 4, 1:45:46 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NAV...
Open
CA$0.01
High
CA$0.01
Low
CA$0.01
Mkt. cap
570.70K
Avg. vol.
4.40K
Volume
3.50K
52-wk high
CA$0.01
52-wk low
CA$0.00
EPS
-CA$0.00
Beta
12.75
Shares outstanding
55.63M
Open
CA$0.01
High
CA$0.01
Low
CA$0.01
Mkt. cap
570.70K
Avg. vol.
4.40K
Volume
3.50K
52-wk high
CA$0.01
52-wk low
CA$0.00
EPS
-CA$0.00
Beta
12.75
Shares outstanding
55.63M
News stories
From sources across the web
About Navco Pharmaceuticals Inc
CEO-
Employees-
Founded-
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Websitenavcopharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.00K
34.77K
2.06K
2.95K
Operating expense
4.00K
34.77K
2.06K
2.95K
Total operating expenses
4.00K
34.77K
2.06K
2.95K
Operating income
-4.00K
-34.77K
-2.06K
-2.95K
Other non operating income
-4.66K
-2.27K
-1.16K
-10.54K
EBT including unusual items
-11.24K
-39.64K
-5.83K
-16.55K
EBT excluding unusual items
-11.24K
-39.64K
-5.83K
-16.55K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11.24K
-39.64K
-5.83K
-16.55K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.58K
-2.61K
-2.61K
-3.06K
Net interest expenses
-2.58K
-2.61K
-2.61K
-3.06K
Depreciation and amortization charges
-
-
-
-
EBITDA
11.55K
-26.38K
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer